1,070
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Design, synthesis, in vitro and in vivo biological evaluation of pterostilbene derivatives for anti-inflammation therapy

, , , , , , , , , & show all
Article: 2315227 | Received 27 Oct 2023, Accepted 07 Jan 2024, Published online: 29 Feb 2024

References

  • Watson N, Ding B, Zhu X, Frisina RD. Chronic inflammation – inflammaging – in the ageing cochlea: a novel target for future presbycusis therapy. Ageing Res Rev. 2017;40:1–13.
  • Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454(7203):428–435.
  • Geiger SS, Essers MAG. Inflammation’s epigenetic footprint in hematopoietic stem cells. Cell Stem Cell. 2020;26(5):611–612.
  • Cain D, Kondo M, Chen H, Kelsoe G. Effects of acute and chronic inflammation on B-cell development and differentiation. J Invest Dermatol. 2009;129(2):266–277.
  • Fullerton JN, O'Brien AJ, Gilroy DW. Lipid mediators in ­immune dysfunction after severe inflammation. Trends Immunol. 2014;35(1):12–21.
  • Han J, Ulevitch RJ. Limiting inflammatory responses during activation of innate immunity. Nat Immunol. 2005;6(12):1198–1205.
  • Clark JD, Flanagan ME, Telliez JB. Discovery and development of Janus kinase (JAK) inhibitors for inflammatory diseases. J Med Chem. 2014;57(12):5023–5038.
  • Willems S, Zaienne D, Merk D. Targeting nuclear receptors in neurodegeneration and neuroinflammation. J Med Chem. 2021;64(14):9592–9638.
  • Salkeni MA, Naing A. Interleukin-10 in cancer immunotherapy: from bench to bedside. Trends Cancer. 2023;9(9):716–725.
  • Lee SH, Kwon JE, Cho ML. Immunological pathogenesis of inflammatory bowel disease. Intest Res. 2018;16(1):26–42.
  • Schneider K, Arandjelovic S. Apoptotic cell clearance components in inflammatory arthritis. Immunol Rev. 2023;28:126–135.
  • Ding Z, Mulder J, Robinson MJ. The origins and longevity of IgE responses as indicated by serological and cellular studies in mice and humans. Allergy. 2023;78(12):3103–3117.
  • Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 diabetes and its impact on the immune system. Curr Diabetes Rev. 2020;16:442–449.
  • Liberale L, Badimon L, Montecucco F, Lüscher TF, Libby P, Camici GG. Inflammation, aging, and cardiovascular disease: JACC review topic of the week. J Am Coll Cardiol. 2022;79(8):837–847.
  • Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V. Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol. 2022;22(11):657–673.
  • Calsolaro V, Edison P. Neuroinflammation in Alzheimer’s disease: current evidence and future directions. Alzheimers Dement. 2016;12(6):719–732.
  • Couto D, Zipfel C. Regulation of pattern recognition receptor signalling in plants. Nat Rev Immunol. 2016;16(9):537–552.
  • Brubaker SW, Bonham KS, Zanoni I, Kagan JC. Innate immune pattern recognition: a cell biological perspective. Annu Rev Immunol. 2015;33(1):257–290.
  • Aghamiri SH, Komlakh K, Ghaffari M. Toll-like receptors (TLRs) and their potential therapeutic applications in diabetic neuropathy. Int Immunopharmacol. 2022;102:1083–1098.
  • Wang J, Zhang J, Wang J, Hu X, Ouyang L, Wang Y. Small-molecule modulators targeting toll-like receptors for potential anticancer therapeutics. J Med Chem. 2023;66(10):6437–6462.
  • Chen LZ, Sun WW, Bo L, Wang JQ, Xiu C, Tang WJ, Shi JB, Zhou HP, Liu XH. New arylpyrazoline-coumarins: synthesis and anti-inflammatory activity. Eur J Med Chem. 2017;138:170–181.
  • Zhang Y, Liang X, Bao X, Xiao W, Chen G. Toll-like receptor 4 (TLR4) inhibitors: current research and prospective. Eur J Med Chem. 2022;235:114291–114301.
  • Li R, Zhou Y, Zhang S, Li J, Zheng Y, Fan X. The natural (poly)phenols as modulators of microglia polarization via TLR4/NF-kappaB pathway exert anti-inflammatory activity in ischemic stroke. Eur J Pharmacol. 2022;914:174660–174668.
  • Bian M, Gong G, Lei P, Du H, Bai C, Wei C, Quan Z, Ma Q. Design, synthesis, and in vitro and in vivo biological evaluation of limonin derivatives for anti-inflammation therapy. J Agric Food Chem. 2021;69(45):13487–13499.
  • Deng R, Wang F, Wang L, Xiong L, Shen X, Song H. Advances in plant polysaccharides as antiaging agents: effects and signaling mechanisms. J Agric Food Chem. 2023;71(19):7175–7191.
  • Ramos-Inza S, Ruberte AC, Sanmartín C, Sharma AK, Plano D. NSAIDs: old acquaintance in the pipeline for cancer treatment and prevention horizontal line structural modulation, mechanisms of action, and bright future. J Med Chem. 2021;64(22):16380–16421.
  • Bindu S, Mazumder S, Bandyopadhyay U. Nonsteroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective. Biochem Pharmacol. 2020;180:114147–114155.
  • Schjerning AM, McGettigan P, Gislason G. Cardiovascular effects and safety of (non-aspirin) NSAIDs. Nat Rev Cardiol. 2020;17(9):574–584.
  • Borchers A, Pieler T. Programming pluripotent precursor cells derived from Xenopus embryos to generate specific tissues and organs. Genes (Basel)). 2010;1(3):413–426.
  • Wu Q, Gao ZJ, Yu X, Wang P. Dietary regulation in health and disease. Signal Transduct Target Ther. 2022;7:240–252.
  • Zampelas A, Magriplis E. Dietary patterns and risk of cardiovascular diseases: a review of the evidence. Proc Nutr Soc. 2020;79(1):68–75.
  • Kim H, Seo KH, Yokoyama W. Chemistry of pterostilbene and its metabolic effects. J Agric Food Chem. 2020;68(46):12836–12841.
  • McCormack D, McFadden D. A review of pterostilbene antioxidant activity and disease modification. Oxid Med Cell Longev. 2013;2013:575482–15.
  • Koh YC, Ho CT, Pan MH. Recent advances in health benefits of stilbenoids. J Agric Food Chem. 2021;69(35):10036–10057.
  • Wu WY, Ding XQ, Gu TT, Guo WJ, Jiao RQ, Song L, Sun Y, Pan Y, Kong LD. Correction to pterostilbene improves hepatic lipid accumulation via the MiR-34a/Sirt1/SREBP-1 pathway in fructose-fed rats. J Agric Food Chem. 2021;69(35):10405–10405.
  • Lin WS, Leland JV, Ho CT, Pan MH. Occurrence, bioavailability, anti-inflammatory, and anticancer effects of pterostilbene. J Agric Food Chem. 2020;68(46):12788–12799.
  • Fang M, Zou T, Yang X, Zhang Z, Cao P, Han J, Duan Y, Ruan BF, Li QS. Discovery of novel pterostilbene derivatives that might treat sepsis by attenuating oxidative stress and inflammation through modulation of MAPKs/NF-kappaB signaling pathways. Antioxidants. 2021;10(9):1333–1350.
  • Wang C, Li J, Qu L, Tang X, Song X, Yang F, Chen X, Lin Q, Lin W, Zhou Y, et al. Discovery of D6808, a highly selective and potent macrocyclic c-met inhibitor for gastric cancer harboring MET gene alteration treatment. J Med Chem. 2022;65(22):15140–15164.
  • Ruan B, Rong M, Ming Z, Wang K, Liu X, Deng L, Zhang X, Xu K, Shi C, Gao T, et al. Discovery of pterostilbene analogs as novel NLRP3 inflammasome inhibitors for potential treatment of DSS-induced colitis in mice. Bioorg Chem. 2023;133:106429–106434.
  • Chen LZ, Shu HY, Wu J, Yu YL, Ma D, Huang X, Liu MM, Liu XH, Shi JB. Discovery and development of novel pyrimidine and pyrazolo/thieno-fused pyrimidine derivatives as potent and orally active inducible nitric oxide synthase dimerization inhibitor with efficacy for arthritis. Eur J Med Chem. 2021;213:113174–113185.
  • Shi JB, Chen LZ, Wang BS, Huang X, Jiao MM, Liu MM, Tang WJ, Liu XH. Novel pyrazolo[4,3-d]pyrimidine as potent and orally active inducible nitric oxide synthase (iNOS) dimerization inhibitor with efficacy in rheumatoid arthritis mouse model. J Med Chem. 2019;62(8):4013–4031.
  • Chen LZ, Wu J, Li K, Wu QQ, Chen R, Liu XH, Ruan BF. Novel phthalide derivatives: synthesis and anti-inflammatory activity in vitro and in vivo. Eur J Med Chem. 2020;206:112722–112731.
  • Yuan Y, Lu L, Bo N, Chaoyue Y, Haiyang Y. Allicin ameliorates intestinal barrier damage via microbiota-regulated short-chain fatty acids-TLR4/MyD88/NF-kappaB cascade response in acrylamide-induced rats. J Agric Food Chem. 2021;69(43):12837–12852.
  • Kou RW, Gao YQ, Xia B, Wang JY, Liu XN, Tang JJ, Yin X, Gao JM. Ganoderterpene A, a new triterpenoid from ganoderma lucidum, attenuates LPS-Induced inflammation and apoptosis via suppressing MAPK and TLR-4/NF-kappaB pathways in BV-2 cells. J Agric Food Chem. 2021;69(43):12730–12740.
  • Zhang L, Yao X, Ma M, Ding Y, Zhang H, He X, Song Z. Protective effect of l-theanine against DSS-induced colitis by regulating the lipid metabolism and reducing inflammation via the NF-kappaB signaling pathway. J Agric Food Chem. 2021;69(47):14192–14203.
  • Xia X, Lin H, Luo F, Wu X, Zhu L, Chen S, Luo H, Ye F, Peng X, Zhang Y, et al. Oryzanol ameliorates DSS-stimulated gut barrier damage via targeting the gut microbiota accompanied by the TLR4/NF-kappaB/NLRP3 cascade response in vivo. J Agric Food Chem. 2022;70(50):15747–15762.
  • Frankish N, Sheridan H. 6-(methylamino)hexane-1,2,3,4,5-pentanol 4-(((1S,2S)-1-hydroxy-2,3-dihydro-1H,1'H-[2,2-biinden]-2-yl)methyl)benzoate (PH46A): a novel small molecule with efficacy in murine models of colitis. J Med Chem. 2012;55(11):5497–5505.